Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.

Hirvonen E, Crona N, Wahlström T, Bäckström AC.

Climacteric. 2000 Dec;3(4):262-70.

PMID:
11910586
4.

One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.

Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.

Maturitas. 2007 Jun 20;57(2):171-81. Epub 2007 Feb 20.

PMID:
17317046
6.

Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.

Ross AH, Boyd ME, Colgan TJ, Ferenczy A, Fugere P, Lorrain J.

Obstet Gynecol. 1993 Nov;82(5):773-9.

PMID:
8414325
7.
8.

Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.

Raudaskoski T, Tapanainen J, Tomás E, Luotola H, Pekonen F, Ronni-Sivula H, Timonen H, Riphagen F, Laatikainen T.

BJOG. 2002 Feb;109(2):136-44.

10.

Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.

Ben-Chetrit A, Hochner-Celnikier D, Lindenberg T, Zacut D, Shimonovitz S, Gelber H, Spitz IM.

Isr Med Assoc J. 2005 May;7(5):302-6.

11.

Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.

Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M; Indivina 321 Study Group.

Menopause Int. 2007 Sep;13(3):124-31.

PMID:
17785038
14.

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.

Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL.

Menopause. 2005 Nov-Dec;12(6):716-27. Epub 2005 Nov 8.

PMID:
16278615
15.

Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.

Yildirim G, Tugrul S, Uslu H, Pekin O, Eren S.

Arch Gynecol Obstet. 2006 Feb;273(5):268-73. Epub 2005 Nov 29.

PMID:
16315025
16.

Comparison of a transdermal continuous combined and an interrupted progestogen HRT.

Cameron ST, Glasier AF, Gebbie A, Dewart H, Baird DT.

Maturitas. 2006 Jan 10;53(1):19-26.

PMID:
16325020
17.

A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.

Mattsson LA, Skouby SO, Heikkinen J, Vaheri R, Mäenpää J, Timonen U.

Climacteric. 2004 Mar;7(1):59-69.

PMID:
15259284
18.

Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.

Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.

Acta Obstet Gynecol Scand. 1998 Aug;77(7):758-63.

PMID:
9740525

Supplemental Content

Support Center